Richard BULLER, MD, PhD

Oncology Diagnostic and Clinical Development Consulting, LLC.

Dr Richard Buller is a clinician scientist whose current role is to provide guidance and insight into oncology drug and diagnostic development based upon his broad experiences in a series of careers over 40 years. In addition to his membership on ImCheck’s Clinical Advisory Board, Rich also serves on the Scientific Advisory Board of InterVenn Biosciences, and the Board of Directors for Celcuity, Inc.

Prior to his current roles, Rich was Vice President of Oncology Clinical Development at Pfizer, Vice President of Translational Oncology at Pfizer, Vice President of Translational Medicine at Exelixis, and a Senior Clinical Director in Oncology Clinical Development and Medical Affairs at GlaxoSmithKline. During this 13-year period he managed progressively larger groups of people including clinicians, translational scientists, clinical pharmacologists, and statisticians. His industry efforts contributed to PMA approvals for two companion diagnostics and more than fifteen successful new or supplemental drug applications, and initial or supplemental marketing applications.

Dr Buller received a BS in Chemistry from UCLA (’71), a PhD in Cell Biology and an M.D. from Baylor College of Medicine (’76,’77).  After a residency in Obstetrics and Gynecology at UCSF, he was in private practice medicine for 7 years. In 1988, Rich left to enter a fellowship in Gynecologic Oncology at UCI. Upon completion in 1990, he joined the faculty of the University of Iowa College of Medicine. Over the next 13 years,  his roles included Division Director as a Professor of Gynecologic Oncology, jointly appointed in Pharmacology, leader of an ovarian cancer research laboratory, and principal investigator in Schering-Plough’s ovarian cancer adenoviral p53 gene replacement program. He authored ~150 basic science, translational and clinical papers, and trained multiple fellows in the delivery of chemotherapy as well as radical pelvic and reconstructive surgery. Rich has received numerous awards and honors including multiple year listings in the Guide to America’s Top Physicians prepared by Consumer Research Council of America. In 2016, he was honored by the UCLA Department of Chemistry and Biochemistry as their Alumnus of the Year.